Bristol-Myers Squibb to Host Investor Teleconference to Discuss World Conference on Lung Cancer (WCLC) Highlights

Bristol-Myers Squibb Company (NYSE: BMY) will host a teleconference onTuesday, September 8 at 8 a.m. EDT (6 a.m. MDT) to review data presented atthe 16(th) Annual World Conference on Lung Cancer (WCLC) in Denver, CO.Company executives will provide an overview of data presented on ourImmuno-Oncology portfolio at the meeting, and address inquiries frominvestors and analysts. Investors and the general public are invited to listen to a live webcast ofthe call at http://investor.bms.com, by dialing U.S. toll-free (877)201-0168 or international (647) 788-4901, confirmation code: 29586971.Materials related to the call will be available at the same website prior tothe call. A replay of the call will be available beginning at 10:30 p.m. EDTon September 8 through 11:59 p.m. EDT on September 23. The replay can beaccessed at http://investor.bms.com or by dialing U.S. toll-free (855)859-2056 or international (404) 537-3406, confirmation code: 29586971.